Frequency and Influence of Hemochromatosis Gene Mutations in Kidney Transplant Recipients With or Without Hepatitis C Virus Infection

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2422-2424

  Ramirez E ^a   Pacho, A ^a   Morales, J M ^a   De Castro, I ^a   Paz Artal, E ^a   Morales, P ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DNA; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IRON; PROTHROMBIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DETERMINATION; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE MUTATION; GRAFT RECIPIENT; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON BLOOD LEVEL; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; FEMALE; GENE FREQUENCY; HEMOCHROMATOSIS; HEPATITIS C; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; MEMBRANE PROTEINS; MUTATION; PROTHROMBIN TIME; REFERENCE VALUES;

EID: 68949218375     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.021     Document Type: Article

References (19)

1. Tung B.Y., Emond M.J., Bronner M.P., et al. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 124 (2003) 318
2. Morales J.M., and Campistol J.M. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 11 (2000) 1343
3. Beaumont C., Simon M., Fauchet R., et al. Serum ferritin as a possible marker of the hemochromatosis allele. N Engl J Med 301 (1979) 169
4. Olsson K.S., Ritter B., Rosen U., et al. Prevalence of iron overload in central Sweden. Acta Med Scand 213 (1983) 145
5. Edwards C.Q., Griffen L.M., Goldgar D., et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318 (1988) 1355
6. Burt M.J., George P.M., Upton J.D., et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43 (1998) 830
7. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399
8. Pacho A., Mancebo E., del Rey M.J., et al. HLA haplotypes associated with hemochromatosis mutations in the Spanish population. BMC Med Genet 5 (2004) 25
9. Mura C., Raguenes O., and Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93 (1999) 2502
10. Wallace D.F., Walker A.P., Pietrangelo A., et al. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. J Hepatol 36 (2002) 474
11. Hanson E.H., Imperatore G., and Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 154 (2001) 193
12. Kirschbaum B. Serial ferritin concentrations in hemodialysis patients receiving intravenous iron. Clin Nephrol 57 (2002) 452
13. Seeff L.B. The natural history of hepatitis C-A quandary. Hepatology 28 (1998) 1710
14. Bacon B.R. Hemochromatosis: diagnosis and management. Gastroenterology 120 (2001) 718
15. Riggio O., Montagnese F., Fiore P., et al. Iron overload in patients with chronic viral hepatitis: how common is it?. Am J Gastroenterol 92 (1997) 1298
16. Rubin R.B., Barton A.L., Banner B.F., et al. Iron and chronic viral hepatitis: emerging evidence for an important interaction. Dig Dis 13 (1995) 223
17. Smith B.C., Gorve J., Guzail M.A., et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27 (1998) 1695
18. Thorburn D., Curry G., Spooner R., et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50 (2002) 248
19. Rossi E., and Jeffrey G.P. Clinical penetrance of C282Y homozygous HFE haemochromatosis. Clin Biochem Rev 25 (2004) 183